In Februari 2022, GliMR published a MAGMA Special Issue, entitled ‘Micro- to Macroscale Magnetic Resonance Imaging of Glioma’, which you can find here.
The aim of this special issue was to promote research that focuses on advancing MRI to improve glioma imaging diagnostics, including original research that either fall within or expand micro- to macroscale assessment of glioma pathophysiology, such as:
- Technical development of advanced MRI for novel biomarkers of glioma
- Rapid acquisition and reconstruction of MRI for multiparametric glioma assessment
- Development of MRI post processing methods for improved glioma diagnostics, such as radiomics and big data analyses, including multi-centre data integration
- Development and validation of novel imaging biomarkers for glioma treatment response and follow-up, including assessing efficacy of novel drugs or distinction of pseudoprogression from treatment effects
This Special Issue comprises 16 articles, many developed by our GliMR members. The issue includes two reviews on dynamic glucose enhanced MRI, advanced MRI for precise radiotherapy, and a systematic review on the use of advanced MRI to detect cancer therapy side effects. We would like to thank the guest editors Dr. Patricia Clement, Prof. Dr. Marion Smits, Prof. Dr. Matthias Van Osch, Prof. Dr. Bruno Costa, and Dr. Esther Warnert, and all our members who submitted their work.
An overview of the included articles:
| Micro- to macroscale magnetic resonance imaging of glioma | Patricia Clement, Marion Smits, Matthias J. P. van Osch, Bruno M. Costa & Esther A. H. Warnert |
| Detection of glioblastoma multiforme using quantitative molecular magnetic resonance imaging based on 5-aminolevulinic acid: in vitro and in vivo studies | Anita Ebrahimpour, Fatemeh Tirgar, Behnam Hajipour-Verdom, Ardeshir Abbasi, Mahmoudreza Hadjighassem, Parviz Abdolmaleki, Saereh Hosseindoost, Seyed Amir Hossein Javadi, Hassan Hashemi, Abbas Rahimi Foroushani, Nader Riyahi Alam & Mehdi Khoobi |
| Feasibility of intravoxel incoherent motion in the assessment of tumor microvasculature and blood–brain barrier integrity: a case-based evaluation of gliomas | Andre Monteiro Paschoal, Maria Clara Zanon Zotin, Lucas Murilo da Costa, Antonio Carlos dos Santos & Renata Ferranti Leoni |
| Feasibility of glioblastoma tissue response mapping with physiologic BOLD imaging using precise oxygen and carbon dioxide challenge | Vittorio Stumpo, Martina Sebök, Christiaan Hendrik Bas van Niftrik, Katharina Seystahl, Nicolin Hainc, Zsolt Kulcsar, Michael Weller, Luca Regli & Jorn Fierstra |
| Diagnostic performance of edited 2HG MR spectroscopy of central glioma in the clinical environment | Dominik Juskanič, Jana Poláková Mištinová, Samuel Hollý, Monika Sekerešová, Kamil Koleják & Lukáš Pátrovič |
| Mapping tumour heterogeneity with pulsed 3D CEST MRI in non-enhancing glioma at 3 T | Esther A. H. Warnert, Tobias C. Wood, Fatih Incekara, Gareth J. Barker, Arnaud J. P. Vincent, Joost Schouten, Johan M. Kros, Martin van den Bent, Marion Smits & Juan A. Hernandez Tamames |
| 3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T Correction to: 3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T | Yulun Wu, Tobias C. Wood, Fatemeh Arzanforoosh, Juan A. Hernandez-Tamames, Gareth J. Barker, Marion Smits & Esther A. H. Warnert |
| GLINT: GlucoCEST in neoplastic tumors at 3 T—clinical results of GlucoCEST in gliomas | Benjamin Bender, Kai Herz, Anagha Deshmane, Vivien Richter, Ghazaleh Tabatabai, Jens Schittenhelm, Marco Skardelly, Klaus Scheffler, Ulrike Ernemann, Mina Kim, Xavier Golay, Moritz Zaiss & Tobias Lindig |
| What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report | Mina Kim, Afroditi Eleftheriou, Luca Ravotto, Bruno Weber, Michal Rivlin, Gil Navon, Martina Capozza, Annasofia Anemone, Dario Livio Longo, Silvio Aime, Moritz Zaiss, Kai Herz, Anagha Deshmane, Tobias Lindig, Benjamin Bender, Xavier Golay on behalf of the GLINT consortium |
| Operator dependency of arterial input function in dynamic contrast-enhanced MRI | Magne Kleppestø, Atle Bjørnerud, Inge Rasmus Groote, Minjae Kim, Jonas Vardal & Christopher Larsson |
| Repeatability of perfusion measurements in adult gliomas using pulsed and pseudo-continuous arterial spin labelling MRI | Amirah Faisal Alsaedi, David Lee Thomas, Enrico De Vita, Jasmina Panovska-Griffiths, Sotirios Bisdas & Xavier Golay |
| The potential of advanced MR techniques for precision radiotherapy of glioblastoma | Patrick L. Y. Tang, Alejandra Méndez Romero, Jaap P. M. Jaspers & Esther A. H. Warnert |
| Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy | A. Gommlich, F. Raschke, J. Petr, A. Seidlitz, C. Jentsch, I. Platzek, J. van den Hoff, J. Kotzerke, B. Beuthien-Baumann, M. Baumann, M. Krause & E. G. C. Troost |
| Evaluation of normal-appearing white matter with perfusion and diffusion MRI in patients with treated glioblastoma | Sinan Şahin, Ersen Ertekin, Tuna Şahin & Yelda Özsunar |
| A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue | Jan Petr, Louise Hogeboom, Pavel Nikulin, Evita Wiegers, Gwen Schroyen, Jesper Kallehauge, Marek Chmelík, Patricia Clement, Ruben E. Nechifor, Liviu-Andrei Fodor, Philip C. De Witt Hamer, Frederik Barkhof, Cyril Pernet, Maarten Lequin, Sabine Deprez, Radim Jančálek, Henk J. M. M. Mutsaerts, Francesca B. Pizzini, Kyrre E. Emblem & Vera C. Keil |
